Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BMS Taps Emory For Clinical Trials In Oncology, Other Areas

This article was originally published in The Pink Sheet Daily

Executive Summary

Bristol-Myers Squibb forms an alliance with Emory University to conduct mid- and late-stage trials in oncology, metabolics, hepatitis C, and immunoscience using BMS compounds.


Related Content

Bristol-Myers Taps Academia To Help Research Immuno-Oncology Pipeline
Micro-Partnerships With Academia Helping To Drive Bristol’s Pipeline Development





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts